VIP
Vantage Investment Partners Portfolio holdings
AUM
$1.37B
This Quarter Return
+15.9%
1 Year Return
+12.18%
3 Year Return
+62.17%
5 Year Return
+88.12%
10 Year Return
+241.63%
AUM
$753M
AUM Growth
+$753M
(-2.6%)
Cap. Flow
-$83.7M
Cap. Flow
% of AUM
-11.12%
Top 10 Holdings %
Top 10 Hldgs %
67.98%
Holding
70
New
3
Increased
20
Reduced
25
Closed
12
Top Buys
| 1 |
Wells Fargo
WFC
|
$124M |
| 2 |
Deutsche Bank
DB
|
$36.4M |
| 3 |
Microsoft
MSFT
|
$19.8M |
| 4 |
M&T Bank
MTB
|
$15.5M |
| 5 |
3M
MMM
|
$11.5M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
$131M |
| 2 |
Bank of America
BAC
|
$34.7M |
| 3 |
Eli Lilly
LLY
|
$12.4M |
| 4 |
Gilead Sciences
GILD
|
$10.3M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$9.87M |
Sector Composition
| 1 | Financials | 57.65% |
| 2 | Industrials | 11.31% |
| 3 | Energy | 8.91% |
| 4 | Consumer Staples | 6.73% |
| 5 | Technology | 5.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Valero Energy
VLO
$48.3B
| $8.01M | 1.06% |
117,292
| – | – |
|
27
Blackstone
BX
$131B
| $7.61M | 1.01% |
281,619
-60,897
| -18% | -$1.65M |
|
28
Phillips 66
PSX
$52.8B
| $7.4M | 0.98% |
85,582
| – | – |
|
29
Colgate-Palmolive
CL
$67.7B
| $4.98M | 0.66% |
76,019
-92,447
| -55% | -$6.05M |
|
30
O'Reilly Automotive
ORLY
$88.1B
| $4.14M | 0.55% |
14,873
-4,157
| -22% | -$1.16M |
|
31
Intel
INTC
$105B
| $3.39M | 0.45% |
93,393
+35,378
| +61% | +$1.28M |
|
32
AT&T
T
$208B
| $3.34M | 0.44% |
78,413
+35,809
| +84% | +$1.52M |
|
33
Capitol Federal Financial
CFFN
$836M
| $3.29M | 0.44% |
200,000
| – | – |
|
34
Lockheed Martin
LMT
$105B
| $3.26M | 0.43% |
13,033
+5,391
| +71% | +$1.35M |
|
35
Vanguard Russell 2000 ETF
VTWO
$12.5B
| $3.14M | 0.42% |
29,067
+2,865
| +11% | +$309K |
|
36
Kimberly-Clark
KMB
$42.5B
| $2.94M | 0.39% |
25,751
+11,846
| +85% | +$1.35M |
|
37
Vanguard S&P 500 ETF
VOO
$724B
| $2.73M | 0.36% |
13,311
+1,264
| +10% | +$260K |
|
38
Southwest Airlines
LUV
$17B
| $2.58M | 0.34% |
51,750
-18,200
| -26% | -$907K |
|
39
Cardinal Health
CAH
$36B
| $1.9M | 0.25% |
26,343
-131,177
| -83% | -$9.44M |
|
40
Alerian MLP ETF
AMLP
$10.6B
| $1.79M | 0.24% |
141,769
+1,856
| +1% | +$23.4K |
|
41
VF Corp
VFC
$5.79B
| $1.77M | 0.24% |
33,159
-179,038
| -84% | -$9.55M |
|
|
42
Eli Lilly
LLY
$661B
| $1.7M | 0.23% |
23,140
-168,210
| -88% | -$12.4M |
|
43
GSK
GSK
$79.3B
| $1.5M | 0.2% |
39,069
-216,180
| -85% | -$8.32M |
|
44
ConocoPhillips
COP
$118B
| $908K | 0.12% |
18,103
-126,579
| -87% | -$6.35M |
|
45
ProPhase Labs
PRPH
$14.9M
| $867K | 0.12% |
433,335
| – | – |
|
46
Vanguard High Dividend Yield ETF
VYM
$63.6B
| $773K | 0.1% |
10,192
+45
| +0.4% | +$3.41K |
|
47
Ford
F
$46.2B
| $706K | 0.09% |
58,222
+9
| +0% | +$109 |
|
48
Vanguard FTSE Developed Markets ETF
VEA
$169B
| $636K | 0.08% |
17,419
+1,632
| +10% | +$59.6K |
|
49
iShares Select Dividend ETF
DVY
$20.6B
| $523K | 0.07% |
5,904
| – | – |
|
50
Vanguard FTSE Emerging Markets ETF
VWO
$96.5B
| $478K | 0.06% |
13,379
+3,078
| +30% | +$110K |
|